piercingiewinsight for sharp investors

← Map · Health Care Equipment · S&P 500

BSX BOSTON SCIENTIFIC CORP

No on this lens

1Reach
1Weight
1Proof
3Total / 15

What they are doing

PFA / Watchman / stents company. The Q2 call was a guidance cut: Watchman referrals and FARAPULSE share loss. OPAL HDx 7.0 mapping software is one line. AI in the 10-K is a risk paragraph. Do not score catheter volume.

Why the score

  • Reach 1 not 2: one thin mapping-software mention.
  • Weight 1 not 2: the fight is catheters, not an intelligence project we can point to.
  • Proof 1 not 2: "improved map quality" is not a result on an algorithm.

What would move it next quarter: OPAL / Cortex described as an algorithm in the case, with a result.

Open these first

Evidence

BSX 10-K (2026-02-17)

OPAL HDx Mapping System: 3-D cardiac mapping and navigation. Digital technologies including AI may increase in applicability. Cyber risk from generative AI.

BSX 10-Q (2026-08-03)

No AI / algorithm hits in the quarter 10-Q.

Q2 transcript

OPAL 7.0 improved map quality. Call is PFA and Watchman.